Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:03 PM
Ignite Modification Date:
2025-12-24 @ 3:03 PM
NCT ID:
NCT00463359
Eligibility Criteria:
Inclusion Criteria:
* Well-defined primary, not previously treated nodulo-cystic BCC
* Size of the lesions: ≤ 1cm diameter
* Facial lesions
* Patient compliance competent
* Patient physically able to apply the treatment (cream)
Exclusion Criteria:
* Recurrent lesions
* Superficial, morphoeic or pigmented BCC
* Lesions close to vital structures; i.e. where C\&C is not considered a standard treatment (eyelids, inner canthus, free borders)
* Lesions within 1 cm of the eyelids, nose, lips and hairline
* Immunosuppressed patients
* Women in childbearing age, pregnancy and breast-feeding
* Ages \<50 or \>90
* Patients compliance incompetent
* Patients physically incapable to apply the treatment (cream)
* Patients with Gorlin Syndrome (nevoid Basal Cell Carcinoma syndrome)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
49 Years
Maximum Age:
89 Years
Study:
NCT00463359
Study Brief:
Protocol Section:
NCT00463359